Stock listing

AXD2 Stock Price, News, Filings & Events — Heron Therapeutics, Inc.

Selected listing: AXD2 · GETTEX · EUR · DE

The AXD2:GETTEX listing page provides insights into Heron Therapeutics, Inc., a biopharmaceutical company focused on developing innovative therapies for patients with unmet medical needs. The company is actively involved in advancing its product pipeline and has recently made updates regarding its clinical trials and regulatory filings. Investors can find relevant news, upcoming events, and detailed filings that reflect Heron's strategic direction and market positioning. This information is crucial for understanding the company's performance and potential in the biopharmaceutical sector.

AXD2:GETTEXEURDEUpdated July 24, 2026
Heron Therapeutics, Inc. logo
Ticker
AXD2:GETTEX
Asset type
Stock
Market cap
$86.3M
Sector
Health Technology
Industry
Biotechnology
Exchange
GETTEX
Currency
EUR

Heron Therapeutics, Inc. AXD2:GETTEX stock context

The AXD2:GETTEX listing page provides insights into Heron Therapeutics, Inc., a biopharmaceutical company focused on developing innovative therapies for patients with unmet medical needs. The company is actively involved in advancing its product pipeline and has recently made updates regarding its clinical trials and regulatory filings. Investors can find relevant news, upcoming events, and detailed filings that reflect Heron's strategic direction and market positioning. This information is crucial for understanding the company's performance and potential in the biopharmaceutical sector.

Research Heron Therapeutics, Inc.

Alternate listings